Search
for

    Sort by

    Research 30 of 81

    1. Re: Can Long-Term LUTS/BPH Pharmacological Treatment Alter the Outcomes of Surgical Intervention? The Journal of Urology · 2017 · 1 citations
    2. Underactive bladder - an underestimated entity Journal of Mind and Medical Sciences · 2020 · 5 citations
    3. Urinary Incontinence due to Overactive Detrusor Muscle: A Rare Side Effect of Venlafaxine Case Reports in Urology · 2015 · 4 citations
    4. The Evolution of Detrusor Overactivity After Watchful Waiting, Medical Therapy and Surgery in Patients with Bladder Outlet Obstruction The Journal of Urology · 2003 · 10 citations
    5. Inhibitory effects of the ATP-sensitive potassium channel openers cromakalim, pinacidil and minoxidil on the carbachol–response curve in porcine detrusor muscle Arab Journal of Urology · 2012 · 3 citations
    6. The lowest effective dose of botulinum toxin in detrusor sphincter dyssynergia Toxicon · 2008 · 1 citations
    7. UP-02.011 Biofeedback Treatment for Dysfunctional Voiding Diagnosed in Adulthood Urology · 2011
    8. titanflow 2026
    9. Anhidrotic effect of intradermal injections of botulinum toxin—A comparison of different products and concentrations Toxicon · 2008
    10. Lower Urinary Tract Symptoms in Men JAMA · 2025
    11. An enzyme-linked immunosorbent assay for detection of botulinum toxin antibodies Toxicon · 2013
    12. Clinical Analysis of Parkinson's Disease with Urinary Bladder Dysfunction:A Report of 64 Cases Chinese Journal of General Practice · 2011
    13. Lower Urinary Tract Symptoms: What’s New in Medical Treatment? European urology focus · 2018 · 22 citations
    14. Micturitional disturbance in a patient with adrenomyeloneuropathy (AMN) Neurourology and Urodynamics · 1998 · 17 citations
    15. UP-02.008 Patients' Characteristics and Urodynamic Parameters of Pressure-Flow Study Failure of Patients in Our Institution Urology · 2011
    16. Pharmacological therapy of benign prostatic hyperplasia/lower urinary tract symptoms: an overview for the practising clinician BJU international · 2004 · 98 citations
    17. Impact of Finasteride on Serum PSA Levels in Men With BPH: A Systematic Review International Journal of Social health · 2025
    18. UP-02.010 Urinary PSA: Marker of Benign Prostatic Hyperplasia? Urology · 2011
    19. The North American Menopause Society Recommendations for Clinical Care of Midlife Women Menopause · 2014 · 254 citations
    20. ADVERSE EFFECTS OF OPIOID ANALGESIC DRUGS British Journal of Anaesthesia · 1987 · 183 citations
    21. K channel therapeutics at the bedside Journal of Molecular and Cellular Cardiology · 2005 · 119 citations
    22. Potassium channel openers: pharmacological and clinical aspects Fundamental & Clinical Pharmacology · 1992 · 119 citations
    23. Endocrine control of benign prostatic hyperplasia Andrology · 2016 · 97 citations
    24. Finasteride Drugs · 1993 · 86 citations
    25. Disease-Modifying Therapy in Multiple Sclerosis: Strategies For Optimizing Management The Neurologist · 2002 · 45 citations
    26. The non-neuronal and nonmuscular effects of botulinum toxin: an opportunity for a deadly molecule to treat disease in the skin and beyond British Journal of Dermatology · 2017 · 44 citations
    27. Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia Frontiers in Pharmacology · 2020 · 35 citations
    28. Long-term Oral Administration of 5α-reductase Inhibitor Attenuates Erectile Function by Inhibiting Autophagy and Promoting Apoptosis of Smooth Muscle Cells in Corpus Cavernosum of Aged Rats Urology · 2013 · 34 citations
    29. Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men Advances in Experimental Medicine and Biology · 2017 · 31 citations
    30. Intraoperative Floppy Iris Syndrome: Updated Perspectives Clinical Ophthalmology · 2020 · 28 citations